These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4994899)

  • 1. [Possibility of the use of biochemical mutants of microorganisms for preliminary characterization of the mechanism of action of new antibiotics].
    Kochetkova GV; Bibikova MV; Il'chenko GB
    Antibiotiki; 1971 Jan; 16(1):53-6. PubMed ID: 4994899
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of Staphylococcus aureus mutants in the search for antineoplastic antibiotics of Actinomycetes origin].
    Kochetkova GV; Il'chenko GB; Kovsharova IN; Rossolimo OK; Proshliakova VV
    Antibiotiki; 1969 Oct; 14(10):900-3. PubMed ID: 5355860
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of the use of Staphylococcus aureus 209 mutant UV-2 at different stages of screening of new antineoplastic antibiotics].
    Kochetkova GV; Il'chenko GB; Kovsharova IN
    Antibiotiki; 1970 Jul; 15(7):587-90. PubMed ID: 4097990
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the selective action of some antibiotics on the mutants of Bacillus subtilis].
    Gauze GF; Bibikova MV; Kochetkova GV; Dudnik IuV
    Antibiotiki; 1966 Dec; 11(12):1063-6. PubMed ID: 4172968
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the suppression of protein synthesis and stimulation of RNA synthesis during the action of some antibiotics on Bacillus subtilis mutants].
    Bibikova MV; Gauze GF; Kochetkova GV
    Antibiotiki; 1969 Jun; 14(6):486-9. PubMed ID: 4979790
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mechanism of action of sibiromycin].
    Gauze GF; Dudnik IuV; Netyksa EM; Laĭko AV; Gauze GG
    Antibiotiki; 1970 Oct; 15(10):867-71. PubMed ID: 4992217
    [No Abstract]   [Full Text] [Related]  

  • 7. [The use of tumor cells for the primary screening of antineoplastic antibiotics].
    Ivanitskaia LP; Makukho LV
    Antibiotiki; 1969; 14(3):221-5. PubMed ID: 5409249
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of different methods for the primary selection of antitumor antibiotics].
    Ivanitskaia LP; Upiter GD
    Antibiotiki; 1967 May; 12(5):369-74. PubMed ID: 5627678
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative evaluation of some methods for primary screening of antineoplastic antibiotics in vitro].
    Rudaia SM; Semenova VA; Osokina LI; Navashin SM
    Antibiotiki; 1970 Mar; 15(3):259-63. PubMed ID: 5467761
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutagenic action of edeine in bacteria. I. Estimation of the minimal mutagenic concentration of antibiotic.
    Tabaczyński MM; Sander-Tabaczyńska A
    Acta Microbiol Pol A; 1970; 2(4):179-83. PubMed ID: 4994235
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of biochemical mutants of test-bacteria in the screening programs with Streptomyces.
    Gause GF
    Hindustan Antibiot Bull; 1968; 10(4):275-7. PubMed ID: 4969598
    [No Abstract]   [Full Text] [Related]  

  • 12. [The action of siderochromes on the incorporation of low-molecular substances into intact bacterial cells].
    Knüsel F; Nüesch J; Scherrer M; Schiess B
    Pathol Microbiol (Basel); 1967; 30(6):900-8. PubMed ID: 4969254
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antineoplastic effect of antibiotics 3002 and 3853].
    Rossolimo OK; Maksimova TS; Sveshnikova MA; Ol'khovatova OL; Kovsharova IN
    Antibiotiki; 1971; 16(4):320-2. PubMed ID: 5109579
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental study of the antimicrobial properties and antineoplastic effect of the new pentaenic antibiotic 661].
    Rossolimo OK; Ivanitskaia LP; Kovsharova IN; Konstantinova NV; Lavrova MF
    Antibiotiki; 1969 Sep; 14(9):849-52. PubMed ID: 4982966
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of the mechanism of action of variamycin].
    Eselevich MM; Sazykin IuO; Torbochkina LI
    Antibiotiki; 1971 May; 16(5):400-4. PubMed ID: 5002220
    [No Abstract]   [Full Text] [Related]  

  • 16. [Selection of Bacillus subtilis mutants blocked at the beginning of sporulation. I. Asporogenous pleotrophic mutants selected by growth in a nitrate medium].
    Michel JF; Cami B; Schaeffer P
    Ann Inst Pasteur (Paris); 1968 Jan; 114(1):11-20. PubMed ID: 4967793
    [No Abstract]   [Full Text] [Related]  

  • 17. On the mode of action of cryomycin.
    Yoshida N; Hanochi H; Hachiya Y; Tani Y; Ogata K
    J Antibiot (Tokyo); 1973 Feb; 26(2):60-4. PubMed ID: 4273623
    [No Abstract]   [Full Text] [Related]  

  • 18. [Natural variability of the producer of amphotericin Act. nodosus Trejo in relation to antibiotic production].
    Zhukova RA; Tsyganov VA; Malyshkina MA
    Antibiotiki; 1968 Apr; 13(4):297-302. PubMed ID: 4970744
    [No Abstract]   [Full Text] [Related]  

  • 19. [Production and properties of staphylococcal mutants].
    Vaamonde R; Nogueira C; Regueiro B
    Microbiol Esp; 1971; 24(2):87-101. PubMed ID: 5135049
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of action of antitumor agents on bacteria. II. Effect of acetyl-kidamycin on nucleic acids.
    Kumazawa M; Inada S; Namiki M; Ishii S; Tago K
    Kitasato Arch Exp Med; 1974 Sep; 47(3):79-88. PubMed ID: 4218625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.